Speaker In-Kind

The following companies with speakers on one or more Keystone Symposia meeting programs have generously agreed to forego reimbursements for speaker travel and lodging expenses.

89bio
Accent Therapeutics
Adimab, Inc.
Agios Pharmaceuticals
Akrevia Therapeutics
Arrakis Therapeutics
Astellas Pharma Inc.
Biogen
Calico
Calico Life Sciences LLC
Celgene Corporation
CORTEVA Agriscience
CRISPR Therapeutics
Fabric Genomics
Fate Therapeutics, Inc.
Forty Seven, Inc.
Genentech, Inc.
Genmab A/S
Gilead Sciences, Inc.
GlaxoSmithKline UK
GSK Foundation
Helixmith Co., Ltd.
Illumina
Immatics Biotechnologies GmbH
Incyte Corporation
InSphero Inc.
Intellia Therapeutics
Kallyope
Light Chain Bioscience
Merck & Co., Inc.
Merck Research Laboratories
Novartis Institutes for BioMedical Research
Novo Nordisk A/S
ORIC Pharmaceuticals
Pairwise
Pfizer Inc.
Pfizer Research Technology Center
Pliant Therapeutics
Promega Corporation
Regeneron Pharmaceuticals, Inc.
Sage Therapeutics
Sangamo Therapeutics, Inc.
Sanofi
Verily
Vincere Biosciences, Inc.